Alpha Sense BI

MARCH 13, 2024

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. Hospital and health system deal activity increased 27% year over year in 2023 , and a flurry of deals has been announced since the beginning of the year.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

SEPTEMBER 15, 2023

Medtech lies at the intersection of two of the most fast-changing and innovative industries—healthcare and technology. With all this technological innovation, the healthcare industry—medtech in particular—is now ripe for investor interest. M&A activity is declining across global markets.

Hospitals 105

Hospitals Due Diligence Innovation Globalization 105

Alpha Sense BI

OCTOBER 6, 2023

Though medical devices are not new to the medtech market, their most recent boom can be attributed to the 2020 global pandemic. Like most other industries, this space was initially adversely affected by COVID-19 due to supply chain issues and reduced budgets for product innovation that brought production to a halt. marketplace.

Hospitals 59

Hospitals Startups Due Diligence Innovation 59

Alpha Sense BI

MAY 5, 2023

After three volatile years, rife with challenging macroeconomic conditions — from a global pandemic and wars to far-reaching supply chain issues — the M&A space has its fair share of ups and downs. ESG is also playing an important role for PE investors, who are increasingly relying on pre-deal ESG due diligence in M&A dealmaking.

Biotech 97

Biotech Capital Banking Startups 97